Efficacy of systemic venous sampling of FGF23 to localize responsible tumors in tumor-induced rickets/osteomalacia
Not Applicable
Recruiting
- Conditions
- Tumor-induced rickets/osteomalacia
- Registration Number
- JPRN-UMIN000031742
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with serious kidney disease(eGFR<30 mL/min/1.73m2). Patients who are pregnant. Patients who are considered ineligible for the study by investigators' decision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whether a combination of systemic venous sampling of FGF23 and imaging studies, such as FDG-PET/CT and octreoscan, shows higher sensitivity and positive predictive value compared to imaging studies alone to localize responsible tumors in TIO.
- Secondary Outcome Measures
Name Time Method